Soni Manmeet Singh — SEC insider filings

SEC reporting owner CIK 1569769. 33 insider filings on record with FilingPulse; latest filed 2026-11-16.

Transaction summary — filings shown

Covers all 33 filings on record, filed 2020-08-14 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
REATA PHARMACEUTICALS INC (RETA)COO, CFO and President153 legs · 19,000 sh · $720,19516 legs · 185,892 sh · $23,382,88223
Summit Therapeutics Inc. (SMMT)COO and CFO, Director113 legs · 3,026,190 sh · $5,722,249—12
PULSE BIOSCIENCES, INC. (PLSE)Director7——8

Insider filings — Soni Manmeet Singh

FiledFormIssuerReported transactionsSource
2026-11-164Summit Therapeutics Inc. (SMMT)Option exercise (M): 100,000 @ $1.37 · Option exercise (M): 100,000 (derivative) @ $0EDGAR
2026-06-154PULSE BIOSCIENCES, INC. (PLSE)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-044Summit Therapeutics Inc. (SMMT)Purchase (P): 25,000 @ $14.46 · Purchase (P): 25,000 @ $14.43EDGAR
2025-10-234Summit Therapeutics Inc. (SMMT)Grant/award (A): 53,361 @ $18.74EDGAR
2025-08-194PULSE BIOSCIENCES, INC. (PLSE)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-05-014Summit Therapeutics Inc. (SMMT)Grant/award (A): 11,200,000 (derivative)EDGAR
2024-09-134Summit Therapeutics Inc. (SMMT)Grant/award (A): 44,052 @ $22.70EDGAR
2024-08-234Summit Therapeutics Inc. (SMMT)Grant/award (A): 2,800,000 (derivative)EDGAR
2024-08-134PULSE BIOSCIENCES, INC. (PLSE)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2024-06-244Pulse Biosciences, Inc. (PLSE)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2024-04-044Summit Therapeutics Inc. (SMMT)Grant/award (A): 1,100,000 (derivative)EDGAR
2023-10-164Summit Therapeutics Inc. (SMMT)Purchase (P): 2,976,190 @ $1.68 · Grant/award (A): 14,000,000 (derivative)EDGAR
2023-09-264REATA PHARMACEUTICALS INC (RETA)Disposition to issuer (D): 62,621 · Disposition to issuer (D): 24,000 (derivative) · Disposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 95,475 (derivative) · Disposition to issuer (D): 175,000 (derivative) · +2 moreEDGAR
2023-08-174REATA PHARMACEUTICALS INC (RETA)Sale (S): 1,755 @ $168.41EDGAR
2023-08-014REATA PHARMACEUTICALS INC (RETA)Conversion (C): 75,000 · Sale (S): 75,000 @ $164.62 · Option exercise (M): 75,000 (derivative) @ $0 · Option exercise (M): 75,000 (derivative) @ $72.70 · Conversion (C): 75,000 (derivative)EDGAR
2023-07-104REATA PHARMACEUTICALS INC (RETA)Grant/award (A): 6,000 @ $0EDGAR
2023-06-144REATA PHARMACEUTICALS INC (RETA)Sale (S): 4,711 @ $99.62 · Option exercise (M): 25,000 @ $27.32 · Sale (S): 9,326 @ $99.75 · Sale (S): 9,157 @ $101.05 · Sale (S): 16,163 @ $101.98 · Sale (S): 3,643 @ $102.73 · +4 moreEDGAR
2023-06-064Pulse Biosciences, Inc. (PLSE)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2023-05-174REATA PHARMACEUTICALS INC (RETA)Sale (S): 12,440 @ $84.32 · Sale (S): 8,867 @ $84.86 · Sale (S): 200 @ $85.64 · Sale (S): 625 @ $80.93EDGAR
2023-05-094REATA PHARMACEUTICALS INC (RETA)Grant/award (A): 50,000 @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2023-03-084REATA PHARMACEUTICALS INC (RETA)Sale (S): 622 @ $84.69EDGAR
2023-03-064REATA PHARMACEUTICALS INC (RETA)Sale (S): 3,587 @ $87.97EDGAR
2023-03-014REATA PHARMACEUTICALS INC (RETA)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2023-01-054Summit Therapeutics Inc. (SMMT)Grant/award (A): 35,000 (derivative)EDGAR
2023-01-044REATA PHARMACEUTICALS INC (RETA)Grant/award (A): 23,513 @ $0 · Grant/award (A): 95,475 (derivative) @ $0EDGAR
2022-05-234Pulse Biosciences, Inc. (PLSE)Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 116,005 (derivative) @ $0EDGAR
2022-01-054REATA PHARMACEUTICALS INC (RETA)Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-01-054Summit Therapeutics Inc. (SMMT)Grant/award (A): 25,000 (derivative) · Grant/award (A): 82,446 (derivative) @ $1.13EDGAR
2022-01-044REATA PHARMACEUTICALS INC (RETA)Purchase (P): 16,000 @ $26.22EDGAR
2021-05-214Pulse Biosciences, Inc. (PLSE)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-02-234Summit Therapeutics Inc. (SMMT)Grant/award (A): 25,000 (derivative)EDGAR
2021-01-064REATA PHARMACEUTICALS INC (RETA)Grant/award (A): 24,000 (derivative) @ $0EDGAR
2020-08-144REATA PHARMACEUTICALS INC (RETA)Purchase (P): 2,000 @ $100.22 · Purchase (P): 1,000 @ $100.19EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1569769 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs